[ESPR] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
23-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -22.28%
YoY- -68.66%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 32,250 18,818 15,401 9,638 982 184,474 0 -
PBT -56,344 -55,487 -65,119 -104,476 -61,946 -60,039 -37,891 6.83%
Tax -27,424 12,974 13,430 8,795 5,165 -74 807 -
NP -56,344 -68,461 -65,119 -104,476 -61,946 -60,039 -37,891 6.83%
Tax Rate - - - - - - - -
Total Cost 88,594 87,279 80,520 114,114 62,928 244,513 37,891 15.19%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -174.71 -363.81 -422.82 -1,084.00 -6,308.15 -32.55 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.50 -0.93 -1.77 -3.89 -2.26 -2.24 -1.44 -16.15%
EPS Diluted -0.50 -0.93 -1.77 -3.89 -2.26 -2.24 -1.44 -16.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.